BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 22517741)

  • 41. O-GlcNAcylation and neurodegeneration.
    Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
    Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteins.
    Zeidan Q; Wang Z; De Maio A; Hart GW
    Mol Biol Cell; 2010 Jun; 21(12):1922-36. PubMed ID: 20410138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The O-β-linked N-acetylglucosaminylation of the Lamin B receptor and its impact on DNA binding and phosphorylation.
    Smet-Nocca C; Page A; Cantrelle FX; Nikolakaki E; Landrieu I; Giannakouros T
    Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):825-835. PubMed ID: 29337275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. O-GlcNAc modification of the extracellular domain of Notch receptors.
    Sakaidani Y; Furukawa K; Okajima T
    Methods Enzymol; 2010; 480():355-73. PubMed ID: 20816217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.
    Tramutola A; Sharma N; Barone E; Lanzillotta C; Castellani A; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Gaetani S; Cassano T; Perluigi M; Di Domenico F
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3309-3321. PubMed ID: 30031227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-acetylglucosamine modification in the lumen of the endoplasmic reticulum.
    Ogawa M; Sawaguchi S; Furukawa K; Okajima T
    Biochim Biophys Acta; 2015 Jun; 1850(6):1319-24. PubMed ID: 25791024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of O-GlcNAc-modified proteins in published large-scale proteome data.
    Hahne H; Gholami AM; Kuster B
    Mol Cell Proteomics; 2012 Oct; 11(10):843-50. PubMed ID: 22661428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
    Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
    J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Engineering a Proximity-Directed O-GlcNAc Transferase for Selective Protein O-GlcNAcylation in Cells.
    Ramirez DH; Aonbangkhen C; Wu HY; Naftaly JA; Tang S; O'Meara TR; Woo CM
    ACS Chem Biol; 2020 Apr; 15(4):1059-1066. PubMed ID: 32119511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 52. A study of the structural properties of sites modified by the O-linked 6-N-acetylglucosamine transferase.
    Britto-Borges T; Barton GJ
    PLoS One; 2017; 12(9):e0184405. PubMed ID: 28886091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EGF promotes PKM2 O-GlcNAcylation by stimulating O-GlcNAc transferase phosphorylation at Y976 and their subsequent association.
    Wang Y; Shu H; Liu J; Jin X; Wang L; Qu Y; Xia M; Peng P; Feng Y; Wei M
    J Biol Chem; 2022 Sep; 298(9):102340. PubMed ID: 35931120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and Characterization of GRASP55 O-GlcNAcylation.
    Zhang X
    Methods Mol Biol; 2023; 2557():743-753. PubMed ID: 36512248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
    Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for a Functional O-Linked N-Acetylglucosamine (O-GlcNAc) System in the Thermophilic Bacterium Thermobaculum terrenum.
    Ostrowski A; Gundogdu M; Ferenbach AT; Lebedev AA; van Aalten DM
    J Biol Chem; 2015 Dec; 290(51):30291-305. PubMed ID: 26491011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification.
    Vosseller K; Sakabe K; Wells L; Hart GW
    Curr Opin Chem Biol; 2002 Dec; 6(6):851-7. PubMed ID: 12470741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
    Johnson B; Opimba M; Bernier J
    Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptide Sequence Mapping around Bisecting GlcNAc-Bearing
    Ohkawa Y; Kizuka Y; Takata M; Nakano M; Ito E; Mishra SK; Akatsuka H; Harada Y; Taniguchi N
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445285
    [No Abstract]   [Full Text] [Related]  

  • 60. Fringe modifies O-fucose on mouse Notch1 at epidermal growth factor-like repeats within the ligand-binding site and the Abruptex region.
    Shao L; Moloney DJ; Haltiwanger R
    J Biol Chem; 2003 Mar; 278(10):7775-82. PubMed ID: 12486116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.